[ExI] etymology of just a piece of paper

[John Clark]

On Tue, Aug 18, 2026 at 2:32 PM <spike at rainier66.com> wrote:

*> the first injection didn’t do anything bad.  The second one did.*


*The probability of a teenager dying from Covid were very low, but the
probability of a teenager dying from the Covid vaccine were even lower.
That's why the recommendation that teenagers continue to receive the Covid
shot did not change. It's a fact of life that Epidemiologists like Dr.
Fauci need to constantly waigh one risk against another, it comes with the
territory and can't be avoided. *


*John K Clark*













>
>
>
> *From:* John Clark <johnkclark at gmail.com>
> *Sent:* Tuesday, 18 August, 2026 11:17 AM
> *To:* spike at rainier66.com
> *Cc:* ExI chat list <extropy-chat at lists.extropy.org>; Kelly Anderson <
> postmowoods at gmail.com>
> *Subject:* Re: etymology of just a piece of paper
>
>
>
>
>
>
>
> On Tue, Aug 18, 2026 at 11:10 AM <spike at rainier66.com> wrote:
>
>
>
> *>**there was a known elevated risk of myocarditis and endocarditis in
> young people who took the vaccine*
>
>
>
> *>…The misinformation* *never ends**!*
>
>
>
> *ME**: Somebody told me that before the Covid vaccine was approved for
> wide scale use there was already a known elevated risk of myocarditis and
> endocarditis in young people who took the vaccine. Is that true?*
>
>
>
>
>
>
>
>
>
>
>
> *John you inserted the word “already.”  If you wish to use Grok as an
> arbiter of truth, just copy/paste exactly what I wrote.  *
>
>
>
> *With the past tense “was” I mean at the time Dr. Fauci received the memo
> from Janet Woodcock, which was well after they started giving the vaccine
> to young people, they had already observed adverse effects, and had noticed
> at the time what plenty of us heard: the first injection didn’t do anything
> bad.  The second one did.*
>
>
>
> *Well OK then.  Just take the first one and let it go.  Perhaps the dosage
> is wrong.  Or take the first one, wait six months, then take the second
> one.  Or split the dose into smaller and more frequent doses.  That
> approach makes the most sense from the theory of immune system response to
> mRNA: cut the dose into twelve and take them monthly.  If the patient still
> experiences problems, cut the dose into 52 portions and take them weekly.  *
>
>
>
> *If you wish to let Grok chew on that one, go ahead.  But do be careful
> with quotes.*
>
>
>
> *spike*
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
> *GROK**: "No.* The elevated risk of myocarditis (inflammation of the
> heart muscle) and pericarditis associated with mRNA COVID-19 vaccines in
> young people—particularly adolescent and young adult males, most often
> after the second dose—was not known before the vaccines received emergency
> use authorization (EUA) for wide-scale use. It emerged as a
> post-authorization safety signal after millions of doses had already been
> administered.
>
> Pfizer-BioNTech (BNT162b2) received FDA EUA on December 11, 2020
> (initially for ages ≥16), and Moderna (mRNA-1273) on December 18, 2020 (for
> ages ≥18). Clinical trial data supporting these authorizations *did not
> identify myocarditis or pericarditis as safety concerns*. The trials were
> large but still underpowered for very rare events, and no associated cases
> were reported in the pre-EUA clinical development for Moderna; similar
> findings held for Pfizer in the main adult trials.
>
> Reports of higher-than-expected myocarditis/pericarditis cases first
> appeared in early 2021 after widespread rollout:
>
>    - Initial signals came from Israel (around February–April 2021, with
>    investigation of cases in Pfizer recipients noted by April), the U.S.
>    Department of Defense (military members), and other surveillance systems.
>    - Broader recognition and investigation accelerated in May–June 2021
>    as more data accumulated from VAERS, other countries, and active
>    surveillance. The CDC’s ACIP and FDA reviewed evidence showing a likely
>    association, concentrated in younger males shortly after dose 2.
>    - FDA *updated EUA fact sheets with warnings about myocarditis and
>    pericarditis in late June 2021 (around June 24–25). CDC/ACIP affirmed that
>    benefits still outweighed risks* in recommended populations while
>    emphasizing awareness and monitoring.
>
> This timeline aligns with how rare adverse events are typically detected:*
> clinical trials catch common or moderately rare issues, but very rare ones
> (on the order of tens of cases per million doses in the highest-risk
> subgroups) often require large-scale post-authorization monitoring*.
> Subsequent observational studies confirmed an elevated risk relative to
> background rates, highest in males roughly 12–29 years old (especially
> after dose 2 of mRNA vaccines), *usually mild/resolving with supportive
> care* in most cases, though still a genuine and labeled risk.
>
> Note that “endocarditis” (infection/inflammation of the heart
> valves/lining) is distinct and was not the primary signal; the documented
> association is with myocarditis and pericarditis. COVID-19 infection itself
> carries a substantially higher risk of myocarditis than vaccination in
> comparative data.
>
> In short, the claim that an elevated risk was already known *before*
> approval/EUA for wide-scale use is not supported by the regulatory and
> scientific record. The signal was identified and acted upon after rollout,
> leading to label updates and ongoing surveillance".
>
>
>
> *John K Clark*
>
>
>
>
>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20260818/100de251/attachment.htm>